ENDOLIFT® and multi-wavelength laser photobiomodulation: a randomized controlled trial study on 96 subjects, treating skin laxity of the lower third of the face
Laser Therapy · 2022-06-30 · 29 (2) · 115-120
DOI: 10.4081/ltj.2022.298 ↗Abstract
Background and aims: Many patients look for procedures that can achieve similar results to surgical lift avoiding the risks and possible complications of surgery. Endolift® and multi-wavelength (MW) Laser photobiomodulation (PBM) are considered two of the most effective procedures in the treatment of skin laxity and superficial wrinkles. We aimed to investigate the reduction of skin laxity of the lower third of the face treated with the Endolift® technique alone or in combination with MW Laser PBM. Materials and Methods: From June 2016 to June 2018, 96 subjects (18 M; 78 F) were included in this randomized controlled trial (RCT) conducted in two Italian institutions. The area treated was the lower third of the face. The subjects were classified using the Ptosis Scale (grade I-V) at T0, with a Pinch Test
EUVIMED